Evidence map›Paper›PMID 41890130›Full record

ArticlebioRxiv : the preprint server for biology2026

Molecular Determinants of Allosteric Inhibitor Affinity and Selectivity in PDE5.

Jyoti Verma, Harish Vashisth

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jyoti VermaDepartment of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, NH.
Harish VashisthDepartment of Chemical Engineering and Bioengineering, University of New Hampshire, Durham, NH.ORCID 0000-0002-2087-2880

Funding

Peptides and Small-molecules Targeting Signaling Proteins and Protein-Protein InterfacesR35GM138217 · NIGMS · UNIVERSITY OF NEW HAMPSHIRE · PI Harish Vashisth · 2020 to 2026
$2.9M
NIGMS NIH HHS R35 GM138217
6 · The paper itself

Abstract

Allosteric inhibitors targeting unique regulatory pockets provide an opportunity for selective modulation of proteins within the phosphodiesterase (PDE) family. In this work, we investigate the molecular determinants for binding of an evodiamine derivative (EVO) to PDE5 and the structural basis for differential recognition of this inhibitor in PDE6 isoforms. We integrated structural modeling, all-atom molecular dynamics (MD) simulations, and extensive alchemical free-energy calculations to quantify residue-level contributions to inhibitor binding in PDE5 through systematic alanine scanning and PDE6-derived mutations. Thermodynamic analysis based on free energy identified key residues that govern EVO binding through a network of hydrogen bonds and hydrophobic contacts. Specifically, we examined structural changes associated with allosteric pocket variations in PDE5, identified key structural elements, and evaluated the role of chemical substituents of EVO in allosteric inhibition. Moreover, PDE6-derived substitutions revealed isoform specific effects, with PDE6-rod substitutions resulting in stronger destabilization than PDE6-cone substitutions. Together, these results define the energetic and structural basis for allosteric inhibition of PDE5 and provide mechanistic insights for the rational design of selective PDE inhibitors.

Indexed as

Allosteric inhibitionAllosteric siteDrug designfree energy perturbationPhosphodieasterase

Identifiers

PMID41890130
PMCPMC13015548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.